Preconditioning enters the era of "physiological proteomics"

被引:1
作者
Cohen, Richard A.
McComb, Mark E.
机构
[1] Boston Univ, Sch Med, Vasc Biol Univ, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, NIH,NHLBI Cardiovasc Proteom Ctr, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Mass Spectrometry Resource Ctr, Boston, MA 02118 USA
关键词
preconditioning; proteomics; ischemia; mitochondria; mass spectrometry;
D O I
10.1161/01.RES.0000245431.16226.c6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:663 / 665
页数:3
相关论文
共 13 条
[1]   Proteomic analysis of pharmacological preconditioning -: Novel protein targets converge to mitochondrial metabolism pathways [J].
Arrell, D. Kent ;
Elliott, Steven T. ;
Kane, Lesley A. ;
Guo, Yurong ;
Ko, Young H. ;
Pedersen, Pete L. ;
Robinson, John ;
Murata, Mitsushige ;
Murphy, Anne M. ;
Marban, Eduardo ;
Van Eyk, Jennifer E. .
CIRCULATION RESEARCH, 2006, 99 (07) :706-714
[2]  
CHEN DM, 2006, IN PRESS J PHARM EXP
[3]   Review - Mass spectrometry and protein analysis [J].
Domon, B ;
Aebersold, R .
SCIENCE, 2006, 312 (5771) :212-217
[4]   Reducing infarct size in the setting of acute myocardial infarction [J].
Downey, JM ;
Cohen, MV .
PROGRESS IN CARDIOVASCULAR DISEASES, 2006, 48 (05) :363-371
[5]   Calcium, mitochondria and reperfusion injury: a pore way to die [J].
Halestrap, AP .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 :232-237
[6]  
*J WIL SONS INC, 2006, RED PROT
[7]   Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics [J].
Kim, N ;
Lee, Y ;
Kim, H ;
Joo, H ;
Youm, JB ;
Park, WS ;
Warda, M ;
Van Cuong, D ;
Han, J .
PROTEOMICS, 2006, 6 (04) :1237-1249
[8]  
Li Hong, 2006, Drug Metabolism and Drug Interactions, V21, P245
[9]   Proteomics in cardiovascular biology and medicine [J].
Loscalzo, J .
CIRCULATION, 2003, 108 (04) :380-383
[10]  
MCCOMB ME, 2004, P 52 ASMS C MASS SPE